Trials / Active Not Recruiting
Active Not RecruitingNCT06913595
Low Molecular Weight Heparin vs Direct Oral Anticoagulant After Bariatric Surgery
Extended Venous Thromboemboism Prophylaxis After Bariatric Surgeries: A Comparison Of Low Molecular Weight Heparin With Direct Oral Anticoagulant
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Extended Venous Thromboemboism Prophylaxis After Bariatric Surgeries: A Comparison Of Low Molecular Weight Heparin With Direct Oral Anticoagulant
Detailed description
This study aims to compare the effectiveness of rivaroxaban versus low molecular weight heparin in reducing the incidence of PMVT after bariatric surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Direct Oral Anticoagulant. | Direct Oral Anticoagulant AFTER BARIATRIC SURGERY |
| DRUG | Low Molecular Weight Heparine | Low molecular weight heparin after bariatric surgery |
Timeline
- Start date
- 2024-03-25
- Primary completion
- 2025-10-25
- Completion
- 2025-11-01
- First posted
- 2025-04-06
- Last updated
- 2025-08-26
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06913595. Inclusion in this directory is not an endorsement.